206 related articles for article (PubMed ID: 21735466)
1. Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.
Mazumdar B; Banerjee A; Meyer K; Ray R
Hepatology; 2011 Oct; 54(4):1149-56. PubMed ID: 21735466
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer.
Meyer K; Beyene A; Bowlin TL; Basu A; Ray R
J Virol; 2004 Dec; 78(23):12838-47. PubMed ID: 15542636
[TBL] [Abstract][Full Text] [Related]
3. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells.
Meyer K; Basu A; Ray R
Virology; 2000 Oct; 276(1):214-26. PubMed ID: 11022009
[TBL] [Abstract][Full Text] [Related]
4. Characterization of pseudotype VSV possessing HCV envelope proteins.
Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
[TBL] [Abstract][Full Text] [Related]
5. Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity.
Beyene A; Basu A; Meyer K; Ray R
Virology; 2004 Jul; 324(2):273-85. PubMed ID: 15207615
[TBL] [Abstract][Full Text] [Related]
6. Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis.
Codran A; Royer C; Jaeck D; Bastien-Valle M; Baumert TF; Kieny MP; Pereira CA; Martin JP
J Gen Virol; 2006 Sep; 87(Pt 9):2583-2593. PubMed ID: 16894197
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus E1 recruits high-density lipoprotein to support infectivity and evade antibody recognition.
Casiano Matos J; Harichandran K; Tang J; Sviridov DO; Sidoti Migliore G; Suzuki M; Olano LR; Hobbs A; Kumar A; Paskel MU; Bonsignori M; Dearborn AD; Remaley AT; Marcotrigiano J
J Virol; 2024 Jan; 98(1):e0084923. PubMed ID: 38174935
[TBL] [Abstract][Full Text] [Related]
8. Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein.
Meyer K; Basu A; Przysiecki CT; Lagging LM; Di Bisceglie AM; Conley AJ; Ray R
J Virol; 2002 Mar; 76(5):2150-8. PubMed ID: 11836392
[TBL] [Abstract][Full Text] [Related]
9. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus.
Lagging LM; Meyer K; Owens RJ; Ray R
J Virol; 1998 May; 72(5):3539-46. PubMed ID: 9557633
[TBL] [Abstract][Full Text] [Related]
10. The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system.
Basu A; Beyene A; Meyer K; Ray R
J Virol; 2004 May; 78(9):4478-86. PubMed ID: 15078928
[TBL] [Abstract][Full Text] [Related]
11. Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain.
Moustafa RI; Haddad JG; Linna L; Hanoulle X; Descamps V; Mesalam AA; Baumert TF; Duverlie G; Meuleman P; Dubuisson J; Lavie M
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068644
[TBL] [Abstract][Full Text] [Related]
12. Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication.
Tamura K; Oue A; Tanaka A; Shimizu N; Takagi H; Kato N; Morikawa A; Hoshino H
Microbes Infect; 2005 Jan; 7(1):29-40. PubMed ID: 15716060
[TBL] [Abstract][Full Text] [Related]
13. Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins.
Tani H; Komoda Y; Matsuo E; Suzuki K; Hamamoto I; Yamashita T; Moriishi K; Fujiyama K; Kanto T; Hayashi N; Owsianka A; Patel AH; Whitt MA; Matsuura Y
J Virol; 2007 Aug; 81(16):8601-12. PubMed ID: 17553880
[TBL] [Abstract][Full Text] [Related]
14. Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells.
Basu A; Kanda T; Beyene A; Saito K; Meyer K; Ray R
J Virol; 2007 Apr; 81(8):3933-41. PubMed ID: 17287282
[TBL] [Abstract][Full Text] [Related]
15. Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.
Haddad JG; Rouillé Y; Hanoulle X; Descamps V; Hamze M; Dabboussi F; Baumert TF; Duverlie G; Lavie M; Dubuisson J
J Virol; 2017 Apr; 91(8):. PubMed ID: 28179528
[TBL] [Abstract][Full Text] [Related]
16. Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins.
Icard V; Diaz O; Scholtes C; Perrin-Cocon L; Ramière C; Bartenschlager R; Penin F; Lotteau V; André P
PLoS One; 2009; 4(1):e4233. PubMed ID: 19156195
[TBL] [Abstract][Full Text] [Related]
17. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.
Majid AM; Ezelle H; Shah S; Barber GN
J Virol; 2006 Jul; 80(14):6993-7008. PubMed ID: 16809305
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing Antibodies.
Fauvelle C; Felmlee DJ; Crouchet E; Lee J; Heydmann L; Lefèvre M; Magri A; Hiet MS; Fofana I; Habersetzer F; Foung SK; Milne R; Patel AH; Vercauteren K; Meuleman P; Zeisel MB; Bartenschlager R; Schuster C; Baumert TF
Gastroenterology; 2016 Jan; 150(1):206-217.e4. PubMed ID: 26404951
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus envelope glycoproteins and potential for vaccine development.
Beyene A; Basu A; Meyer K; Ray R
Vox Sang; 2002 Aug; 83 Suppl 1():27-32. PubMed ID: 12617098
[TBL] [Abstract][Full Text] [Related]
20. PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolism.
Bridge SH; Sheridan DA; Felmlee DJ; Crossey MM; Fenwick FI; Lanyon CV; Dubuc G; Seidah NG; Davignon J; Thomas HC; Taylor-Robinson SD; Toms GL; Neely RD; Bassendine MF
J Hepatol; 2015 Apr; 62(4):763-70. PubMed ID: 25463543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
